The Chilean startup dedicated to manufacturing personalized implants by 3D printing, was selected by The Ganesha Lab, an accelerator specialized in biotech that operates in Latin America, and is dedicated to bringing science and technology startups to the North American market, accompanying them in the landing and growth process in the US.

arcomedlab has implanted 500 units during the last year in patients from Mexico, Brazil, Peru, Argentina and Spain as well as Chile. In this regard, Ilan Rosenberg, general manager of the startup points out that, with this milestone, they have committed to selling at least 10 implants next year in the North American market. “We should double sales in 2023,” he adds.